Compass Pathways

Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. They are focused on developing and researching psilocybin therapy as a treatment for various mental health conditions, including treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa. Their approach involves a proprietary formulation of synthetic psilocybin, called COMP360, administered with psychological support. They believe this model will set a new standard for mental healthcare by combining medicine, psychological support, and digital interventions.

Compass Pathways is also deeply committed to social responsibility, prioritizing diversity, equity, and inclusion in all aspects of their work. This includes their therapist training program, research protocols, and their engagement with patient communities. They strive to create a supportive and inclusive work environment, while also actively minimizing their environmental impact. Their mission extends beyond simply developing new therapies; they are working to build a mental health ecosystem that supports care models of the future, promotes access, and ensures health equity over the long term.

Compass Pathways offers flexible working arrangements for its employees, with the option to work remotely from home in the United Kingdom or work a hybrid schedule from their office in Soho, London. This flexibility allows employees to choose a work environment that best suits their needs and preferences, promoting a healthy work-life balance.

Compass Pathways offers a comprehensive benefits package to its employees, designed to support their overall well-being. These benefits include competitive compensation, company-paid health insurance, flexible work arrangements, a holistic wellbeing program encompassing both mental and physical health, and a supportive workplace culture that encourages open communication and prioritizes employee well-being.

Compass Pathways is a biotechnology company committed to revolutionizing mental healthcare by accelerating access to evidence-based innovations. Their primary focus is the development of psilocybin therapy, administered alongside psychological support, as a treatment for severe mental health conditions such as treatment-resistant depression, PTSD, and anorexia nervosa. By developing innovative therapies, fostering a supportive mental health ecosystem, and promoting responsible business practices, Compass Pathways strives to create a world where mental wellbeing is achievable for everyone.

Compass Pathways promotes a culture of compassion, boldness, rigor, and inclusivity, reflecting their commitment to reimagining mental healthcare. They prioritize a supportive and collaborative work environment where individuals feel valued and empowered to contribute their unique perspectives and experiences. The company fosters open communication, encourages professional development, and promotes a holistic approach to wellbeing, recognizing the importance of both physical and mental health.

Compass Pathways is committed to fostering a diverse and inclusive workplace that reflects the patients they serve. They prioritize diversity in their hiring practices and have implemented policies and training programs to support equity and inclusion across the organization. Compass recognizes the importance of cultural humility in their work and has established a DEI advisory group to guide their initiatives. They are dedicated to creating a workplace where everyone feels valued, respected, and empowered to contribute their unique perspectives.